Latest Trials
Latest News
Products
FAQ
Pharmaceutical Companies
Pharma Details
University Of California, San Francisco
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Inhaled NO in Prevention of Chronic Lung Disease
Phase 3
Completed
Conditions
Bronchopulmonary Dysplasia
Lung Diseases
Subscribe
First Posted Date
1999-10-28
Last Posted Date
2015-03-05
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00000548
Subscribe
Prev
1
192
193
194
195
196
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy